| ¿µ¹® | sodium | ÇÑ±Û | ³ªÆ®·ý |
|---|---|---|---|
| ¼³¸í | ¿øÀÚ¹øÈ£ 11ÀÇ ±Ý¼Ó¿øÀÚ. ¼¼Æ÷ ¿Ü¾×ÀÇ °¡Àå ÈçÇÑ ¾çÀÌ¿ÂÀ¸·Î¼ ¼¼Æ÷ ¿Ü¾×ÀÇ »ïÅõ¾Ð°áÁ¤¿¡ °¡Àå Áß¿äÇÑ ¿ªÇÒÀ» ÇÔ. ¾Ëµµ½ºÅ×·Ð(aldosterone: ÄáÆÏÀ§¿¡ ÀÖ´Â ºÎ½Å¿¡¼ ºÐºñÇÑ´Ù. Ç÷¾×³»ÀÇ »ïÅõ¾ÐÀ¯Áö¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù)¿¡ ÀÇÇØ ÄáÆÏ¿¡¼ ÀçÈí¼ö°¡ ÃËÁøµÇ¸ç ü³» ¼öºÐ·®À» °áÁ¤ÇÏ´Â °¡Àå Áß¿äÇÑ ÀÎÀÚ. ½Å°æ¼¼Æ÷ µîÀÇ ÈïºÐ¼º ¼¼Æ÷ÀÇ ÈïºÐ½Ã ¼¼Æ÷³»·Î À¯ÀԵǾî ÈïºÐÀ» À¯¹ßÇÏ´Â Áß¿äÇÑ ±â´Éµµ °¡Áø´Ù. |
||
| ¿µ¹® | vinyl chloride | ÇÑ±Û | ¿°Èºñ´Ò |
|---|---|---|---|
| ¼³¸í | ÁÖ·Î °ø¾÷üÀÇ Àý¿¬Ã¼³ª, ½ºÇÁ·¹ÀÌ, °ø¾÷¿ëÈÇÐÁ¦·Î ¾²ÀδÙ. ÀÎü¿¡ ¾ÏÀ» À¯¹ßÇÒ ¼ö ÀÖ´Â ¹ß¾ÏÁ¦·Î ¾Ë·ÁÁ® ÀÖ´Ù. |
||
| ¿µ¹® | potassium | ÇÑ±Û | Ä®·ý |
|---|---|---|---|
| ¼³¸í | ¿ø¼Ò ±âÈ£ 19¹øÀ̰í K·Î Ç¥½ÃÇÏ´Â ÈÇÐÀû ¿ø¼Ò·Î ¼¼Æ÷ ³»¾×ÀÇ °¡Àå ¸¹Àº ¾çÀÌ¿ÂÀ̱⵵ ÇÏ´Ù. |
||
| PSL | parasternal line; photostimulable luminescence; potassium, sodium chloride, and sodium lactate [solu... |
|---|---|
| MAOI | MonoAmine Oxidase Inhibitors |
| SAGM | sodium chloride, adenine, glucose, mannitol |
| Na,K-ATPase | sodium-potassium adenosine triphosphatase |
| DOSS | distal over-shoulder strap; dioctyl sodium sulfosuccinate; docusate sodium |
| hNIS | Human sodium iodide symporter |
|---|---|
| NIS | Na(+)-I- symporter |
| KATP | ATP dependent potassium |
| K(ATP) | ATP sensitive potassium |
| KATP channel | ATP sensitive potassium channel |
potency
| symporter | The protein responsible for mediating symport. (05 Mar 2000) |
|---|---|
| potassium chloride | <chemical> Potassium chloride. A white crystal or crystalline powder used as an electrolyte replenisher, in the treatment of hypokalaemia, in buffer solutions, and in fertilisers and explosives. Chemical name: Potassium chloride (KCl) (12 Dec 1998) |
| potassium sodium tartrate | KNaC4H4O6;a mild saline cathartic, used as an ingredient in compound effervescent powders. Synonym: Rochelle salt, Seignette's salt, sodium potassium tartrate. (05 Mar 2000) |
| sodium potassium ATPase | <enzyme> A major transport protein of the plasma membrane. A multi unit enzyme, it moves 3 sodium ions out of the cell and 2 potassium ions in, for each ATP hydrolysed. The sodium gradient established is used for several purposes (see facilitated diffusion, action potential), while the potassium gradient is dissipated through the potassium leak channel. Must not be confused with a sodium channel. (18 Nov 1997) |
| sodium-potassium-exchanging atpase | <enzyme> An enzyme that catalyses the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane atpase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients. Chemical name: ATP phosphohydrolase (sodium-potassium-transporting) Registry number: EC 3.6.1.37 (12 Dec 1998) |
| sodium-potassium pump | A membrane-bound transporter that maintains the high potassium and low sodium intracellular concentrations relative to the extracellular medium. This exchange is accomplished at the expense of cellular energy in the form of ATP. (05 Mar 2000) |
| sodium potassium tartrate | KNaC4H4O6;a mild saline cathartic, used as an ingredient in compound effervescent powders. Synonym: Rochelle salt, Seignette's salt, sodium potassium tartrate. (05 Mar 2000) |
| sodium chloride | <chemical> Table salt, NaCL. (09 Oct 1997) |
| sodium chloride, dietary | Sodium chloride used in foods. (12 Dec 1998) |
| adrenergic uptake inhibitors | Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (antidepressive agents, tricyclic) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (12 Dec 1998) |
| blood coagulation factor inhibitors | Substances, usually endogenous, that act as inhibitors of blood coagulation. They may affect one or multiple enzymes throughout the process. As a group, they also inhibit enzymes involved in processes other than blood coagulation, such as those from the complement system, fibrinolytic enzyme system, blood cells, and bacteria. (12 Dec 1998) |
| Bowman Birk protease inhibitors | <pharmacology> Family of serine protease inhibitors found in seeds of leguminous plants and cereals. (18 Nov 1997) |
| carbonic anhydrase inhibitors | A class of compounds that reduces the secretion of h+ ions by the proximal kidney tubule through inhibition of carbonic anhydrase (carbonate dehydratase). Although their therapeutic use as diuretics is not frequent, they are used in clinical conditions where alkalinization of the urine is beneficial. Their most frequent application is in the reduction of intra-ocular pressure in the treatment of glaucoma. (12 Dec 1998) |
| reverse transcriptase inhibitors | Inhibitors of reverse transcriptase (RNA-directed DNA polymerase), an enzyme that synthesises DNA on an RNA template. (12 Dec 1998) |
| growth inhibitors | Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= plant growth regulators). (12 Dec 1998) |
Synonyms : Bumetanide Sensitive Na-K-Cl-Transporter Inhibitors, High Ceiling Diuretics, Loop Diuretics, Na-K-CL Symporter Inhibitors, Sodium Potassium Chloride Cotransporter Inhibitors, Bumetanide Sensitive Na K Cl Transporter Inhibitors, Ceiling Diuretics, High
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|